Account
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Articles
08.08.2023
How to get payer scientific advice between now and...

Our market access experts provide an overview of how to get payer scientific advice between Septembe...

Read more
Case Study
27.01.2023
Payer value proposition development

Payer value proposition development and understanding evidence requirements to secure pricing and re...

Read more
Articles
26.01.2023
What have we learned from the UK EAMS process?

Almost a decade after it's inception, what have we learned from the UK early access to medicines sch...

Read more
Articles
13.04.2022
How do you win the race to market? Our top conside...

Introduction Early Access Programs, also known as special access programs, give patients access to m...

Read more
Insider Insights
01.02.2022
Proposals for reforming public and private health

The report looks at four possible scenarios including most notably the creation of a “grande Sécu...

Read more
Articles
11.05.2021
Market access training for speciality products

Securing patient access in specialty products is becoming increasingly challenging due to the comple...

Read more
Publications
27.09.2018
Key considerations for payer scientific advice

This research highlights the variability regarding the scientific advice submission processes and sc...

Read more
Articles
05.12.2015
Early payer scientific advice in the EU

There are now European platforms for seeking early scientific advice with multiple payer organisatio...

Read more
Articles
25.11.2015
Securing earlier patient access

The aim of MAPPs is to enable quicker access for patients whilst providing adequate and evolving evi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.